alendronate sodium trihydrate
ItalyDrugs containing this active substance
-
It is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronate sodium trihydrate - cholecalciferol - ATC: M05BB03
Manufacturer: N.V. ORGANON
-
This medicine is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronate sodium trihydrate - cholecalciferol - ATC: M05BB03
Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.
-
This medicine is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of spinal and hip fractures.
Form: tablets
Active substance Dosage alendronate sodium trihydrate - cholecalciferol - ATC: M05BB03
Manufacturer: MYLAN S.P.A.
-
It is prescribed for the treatment of postmenopausal osteoporosis. The drug helps prevent the loss of bone tissue, promotes bone rebuilding, and reduces the risk of hip and spinal fractures.
Form: tablets
Active substance Dosage alendronate sodium trihydrate - ATC: M05BA04
Manufacturer: GENETIC S.P.A.
-
Alendros is used to treat osteoporosis, a disease that makes bones fragile and prone to fractures, in both men and women after menopause. It is also used to treat and prevent osteoporosis caused by the use of a specific class of anti-inflammatory drugs called glucocorticoids.
Form: tablets
Active substance Dosage alendronate sodium trihydrate - ATC: M05BA04
Manufacturer: ABIOGEN PHARMA S.P.A.
-
It is used for the treatment of osteoporosis in postmenopausal women, with the aim of reducing the risk of hip and vertebral fractures.
Form: tablets
Active substance Dosage alendronate sodium trihydrate - ATC: M05BA04
Manufacturer: EBERLIFE FARMACEUTICI S.P.A.
-
The medication is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent bone tissue loss, promote bone rebuilding, and reduce the risk of hip and spinal fractures.
Form: tablets, film-coated
Active substance Dosage alendronate sodium trihydrate - ATC: M05BA04
Manufacturer: SO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI
-
It is used for the treatment of osteoporosis in postmenopausal women, helping to prevent bone loss, rebuild bone, and reduce the risk of vertebral and hip fractures.
Form: tablets, film-coated
Active substance Dosage alendronate sodium trihydrate - ATC: M05BA04
Manufacturer: S.F. GROUP S.R.L.